Methicillin-resistant Staphylococcus aureus dacryoadenitis

JAMA Ophthalmol. 2014 Aug;132(8):993-5. doi: 10.1001/jamaophthalmol.2014.965.

Abstract

Importance: Although classically thought to be primarily a nosocomial infection, the incidence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) is rising. In this series we report 3 cases of community-acquired MRSA acute dacryoadenitis in adults presenting within a 3-week period.

Observations: All cases presented with pain and periocular erythema increasing over approximately 1 week. An S-shaped lid deformity was evident, and 2 of the 3 cases demonstrated multiple pustules/abscesses in the region of the lacrimal gland that were expressing purulent fluid into the superior fornix. Eye cultures yielded MRSA. Each case had complete clinical resolution with 2 to 4 days of intravenous vancomycin followed by 1 week of oral trimethoprim-sulfamethoxazole combination therapy.

Conclusions and relevance: These cases underscore the changing profile of MRSA infections, especially in the community-based setting. MRSA dacryoadenitis can be difficult to treat with standard therapeutic approaches and may progress to orbital cellulitis. We recommend a short admission for intravenous antibiotic therapy while bacterial sensitivities are being determined before transitioning to a dual-targeted oral antibiotic regimen.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Dacryocystitis / drug therapy*
  • Female
  • Humans
  • Male
  • Methicillin-Resistant Staphylococcus aureus*
  • Staphylococcal Infections / drug therapy*